SCHEMBL4446018

SCHEMBL4446018

O=C(O)c1cc(OCc2ccc(Br)cc2F)ccc1NC(=O)C1CC1.O=C(O)c1cc(OCc2ccc(C(F)(F)F)cc2Cl)ccc1NC(=O)C1CC1.O=C(O)c1cc(OCc2ccc(Cl)cc2F)ccc1NC(=O)C1CC1.O=C(O)c1cc(OCc2ccc(F)cc2Cl)ccc1NC(=O)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.42
BRAF P15056 6/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PTGER1 P34995 1/20 0.38
F10 P00742 1/20 0.37
MRGPRX4 Q96LA9 2/20 0.37
AKR1B1 P15121 1/20 0.36
NR4A2 P43354 1/20 0.36
PIM1 P11309 1/20 0.36
PDGFRA P16234 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR5 Q9H228 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826609 0.86 KDM4E (0.49) KDRBRAFKMT2AMEN1TSHR
SCHEMBL1826827 0.83 KDM4E (0.50) KDRBRAFKMT2AMEN1TSHR
SCHEMBL1822929 0.83 KDM4E (0.52) KMT2AMEN1KDM4EHSD17B10F10
SCHEMBL1823741 0.83 KMT2A (0.58) KDRBRAFKMT2AKDM4EHSD17B10
SCHEMBL1823309 0.83 KDM4E (0.52) KMT2AMEN1KDM4EHSD17B10PTGER1
SCHEMBL1824677 0.82 KDM4E (0.52) KMT2AMEN1KDM4EHSD17B10NR4A2
SCHEMBL4448039 0.80 KDM4E (0.41) KDRBRAFKMT2AMEN1TSHR
SCHEMBL1827202 0.80 KDM4E (0.54) KMT2AKDM4EHSD17B10PTGER1F10
SCHEMBL1825586 0.80 NR4A2 (0.55) KMT2AMEN1KDM4EHSD17B10NR4A2
SCHEMBL1824122 0.79 KDM4E (0.49) KDRBRAFKMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118051-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF Chelsea Therapeutics, Inc. (US) 2009-11-18 EP claimed
WO-2008097180-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF CHELSEA THERAPEUTICS, INC. (US) 2008-08-14 WO claimed